已收盘 12-19 16:00:00 美东时间
+0.300
+11.07%
HeartBeam shares jumped 40.75% in after-hours trading after the company outlined its regulatory strategy following the FDA's Not Substantially Equivalent decision.
11-27 14:37
Immediately following the receipt of the NSE letter and through today, HeartBeam has been engaging with the Food and Drug Administration (FDA) review staff to better understand the concerns and determine the best path
11-27 05:42
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
HeartBeam (NASDAQ:BEAT) is gearing up to announce its quarterly earnings on Thu...
11-13 00:03
(来源:研报虎) 创新药专题:OS终点失败的3期临床试验有哪些潜在原因?对新兴的肿瘤治疗药物,美国FDA对OS数据的要求正日益严格,CDE监管环境与国际接轨...
07-16 22:20
封面新闻记者付文超欧阳宏宇易弋力 网易云音乐BEATSOUL激励计划上线 近日,网易云音乐正式推出BEATSOUL激励计划...
07-09 19:00
Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.
2024-09-04 19:55